Amid crowded migraine market, Lundbeck goes its own wayThe market for migraine treatment and prevention has been transformed by the launch of several new drugs targeting Share XAmid crowded migraine market, Lundbeck goes its own wayhttps://pharmaphorum.com/news/amid-crowded-migraine-market-lundbeck-goes-its-own-way/
Lundbeck taps Inscopix’ brain-mapping camera tech for CNS researchDanish drugmaker Lundbeck has teamed up with Inscopix – the developer of a technology that can film neurons Share XLundbeck taps Inscopix’ brain-mapping camera tech for CNS researchhttps://pharmaphorum.com/news/lundbeck-taps-inscopix-brain-mapping-camera-tech-for-cns-research/
Lundbeck tops Q3 expectations following strong sales of mental health drugsDenmark’s Lundbeck has beat its expectations in third quarter results, following a strong performance from its portfolio of Share XLundbeck tops Q3 expectations following strong sales of mental health drugshttps://pharmaphorum.com/news/lundbeck-tops-q3-expectations-following-strong-sales-of-mental-health-drugs/
Lundbeck announces plans to cut a fifth of R&D workforceLundbeck has announced plans to cut its research and development team, which could lead to a reduction of Share XLundbeck announces plans to cut a fifth of R&D workforcehttps://pharmaphorum.com/news/lundbeck-announces-plans-to-cut-around-160-rd-jobs/
FDA approves ‘potential blockbuster’ migraine jab from LundbeckThe FDA has approved Lundbeck’s eptinezumab prophylactic treatment for migraine, the last from a gang of four drugs Share XFDA approves ‘potential blockbuster’ migraine jab from Lundbeckhttps://pharmaphorum.com/news/fda-approves-potential-blockbuster-migraine-jab-from-lundbeck/
Lundbeck’s digital strategy and how they manage global and local contentLike all large pharmaceutical companies, Lundbeck operates and manages many different digital marketing and information channels. The Danish Share XLundbeck’s digital strategy and how they manage global and local contenthttps://pharmaphorum.com/sales-marketing/lundbecks-digital-strategy-and-how-they-manage-global-and-local-content/
Lundbeck joins with Elsevier to help manage R&D dataDenmark’s Lundbeck has signed an agreement with information business Elsevier, that aims to help organise the masses of Share XLundbeck joins with Elsevier to help manage R&D datahttps://pharmaphorum.com/news/lundbeck-joins-with-elsevier-to-help-manage-rd-data/
Lundbeck craters as resistant schizophrenia drug fails phase IIIDanish drugmaker Lundbeck saw more than a quarter of the value wiped off its shares yesterday after its Share XLundbeck craters as resistant schizophrenia drug fails phase IIIhttps://pharmaphorum.com/news/lundbeck-craters-as-resistant-schizophrenia-drug-fails-phase-iii/
Lundbeck brings third Parkinson’s drug into clinicDenmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody Share XLundbeck brings third Parkinson’s drug into clinichttps://pharmaphorum.com/news/lundbeck-brings-third-parkinsons-drug-into-clinic/
